Résumé
Elucidation of the molecular and cellular basis of joint destruction in rheumatoid arthritis is revealing novel targets for gene transfer therapy of this disease. A recent meeting
3
The first workshop of the European Study Group of Gene Therapy in Osteoarticular Diseases was held on Montpellier, France, on 27 February 1998.
3
evaluated progress in gene delivery systems and discussed future strategies.